Master of Global Medicines Development

Fed Square group sitting down

New in 2026, the Master of Global Medicines Development is a unique degree jointly offered by two of the highest-ranked schools in pharmacy and pharmacology in the world*.

Together, Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences and the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill will deliver this program, designed for students who aspire to leadership, coordination or administrative roles within a global medicines context.

*2026 QS World Rankings by subject: Monash University ranks #2, The University of North Carolina ranks #5

Learn more about the Master of Global Medicines Development at our upcoming in-person and online events. 

Register now for our 2026 Graduate Open Evening (6 October) or our upcoming webinars covering both the Master of  Pharmaceutical Science and the Master of Global Medicines Development (13 October); or focussing just on the Master of Global Medicines Development (8 December).

Applications for semester 1 2027 will open on 1 August 2026 and close on 31 January 2027.

Why study the Master of Global Medicines Development?

In our increasingly interconnected world, emerging diseases require an international approach to drug discovery and development, its regulatory frameworks and supply chain logistics. Against the backdrop of constantly changing global environments, skilled professionals with the expertise to coordinate drug development activities with cross-border perspectives will be in demand.


Hear from our students

As part of the Pharmacy degree, Prianka had the opportunity to have an international experience at the University of North Carolina at Chapel Hill.

Course code: P6006 Master of Global Medicines Development CRICOS: 118224D